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Background: Earlier laboratory studies have shown that sodium tetrachloropalladate,
Myroxylon pereirae, caine mix II, and palladium chloride trigger the release of alumin-
ium (Al) from Finn Chambers (FC).
Objectives: To investigate whether aluminium realease from FC could influence the
diagnostic outcome of patch testing with FC.
Method: A retrospective analysis of patch test results from 2010 to 2019 was per-
formed. A two-sided Fisher's exact test was used to calculate any overrepresentation
of contact allergy to Al among patients with positive reactions to sodium
tetrachloropalladate, Myroxylon pereirae, caine mix II, and palladium chloride.
Results: A total of 5446 patients had been tested with FC during the study period.
There was a significant overrepresentation of contact allergy to Al among patients
with positive reactions to sodium tetrachloropalladate, Myroxylon pereirae, caine mix
II, and palladium chloride. Patients with a strong Al allergy had significantly higher
amounts of concomitant reactions to sodium tetrachloropalladate, Myroxylon
pereirae, caine mix II, and palladium chloride compared to patients with weak Al
allergy. These results were not seen for patients tested with Finn Chambers AQUA.
Conclusion: In patients with contact allergy to Al, patch testing with Finn chambers
could give false-positive reactions to sodium tetrachloropalladate, Myroxylon pereirae,
caine mix II, and palladium chloride.
K E YWORD S
aluminium corrosion, caine mix II, contact allergy to aluminium, Finn chambers, Myroxylon
pereirae, palladium chloride, sodium tetrachloropalladate
1 | INTRODUCTION
Patch testing is an in vivo test considered to be the gold standard in
the diagnosis of contact allergy. Patch testing needs to be performed
under standardized procedures, and taking into consideration all prac-
tical aspects from storage and purity of test substances, through load-
ing and applying the chambers, to reading the results.1-7 The
European Society of Contact Dermatitis recommends optimal dosing
for Finn chambers (aluminium chambers; SmartPractice, Phoenix, Ari-
zona), Van der Bend chambers (plastic chambers; Van der Bend Medi-
cal Supplies, Brielle, Netherlands), and IQ chambers (plastic chambers;
Chemotechnique Diagnostics, Vellinge, Sweden), which are the three
most commonly used test chamber systems.7 Finn chambers (FCs) are
made of aluminium (Al), which is normally a passive (non-corroding)
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metal. When in contact with air or water it forms a thin surface layer
of Al oxide, which makes the metal resistant to corrosion.8 As with
most passive metals, it might, however, locally corrode under certain
conditions, such as in the presence of salts.8
The prevalence of contact allergy to Al is low9 and patients with
contact allergy to Al do not normally react to an empty FC.10 This sug-
gests that FCs are a safe choice in standard patch testing. A new sys-
tem, Finn Chamber AQUA (FCA), has been developed, for which the
Al chamber is coated with absorbent paper. This test system was
developed to resist moisture and remain in place even during exercise
and showers.11
New chemical analyses from Hedberg et al. show, however, that
various patch test preparations can induce Al release from Finn cham-
bers in vitro due to Al corrosion.12 In the study, different batches of
FC and FCA were investigated with 32 different baseline prepara-
tions. These were exposed to artificial sweat containing 5.0 g/L NaCl,
1.0 g/L urea, 1.0 g/L lactic acid, with the pH adjusted to 6.5.12 It was
found that sodium tetrachloropalladate hydrate (Na-Pd) 3% pet. and
caine mix II (CM II), 10% pet. released significantly higher amounts of
Al compared to an Al Finn Chamber in artificial sweat. Palladium chlo-
ride (Pd-Cl) 2% pet. and Myroxolon pereirae (MP) 25% pet. also
induced increased Al release in FC, although not statistically signifi-
cant.12 The explanation for the Al release is that surface-available
chlorides from metal salts can cause localised corrosion (pitting corro-
sion) to Al metal.8,12 Several metal salts used for patch testing contain
chloride ions. Acids, especially in the combination with chlorides from
sweat, can also cause corrosion to Al metal.13 MP contains high
amounts of organic acid and CM II contains hydrochloric acid, which
is corrosive to Al.12 The Al -release from FC into artificial sweat was
found to be 16–4100-fold higher than the Al release from FCA.
FC with 8 mm inner diameter have been used for the past
40 years, until 2017, as standard chambers when patch testing at the
Department of Occupational and Environmental Dermatology, Skåne
University Hospital Malmö, Sweden. As a result of a change in work
routines in 2018, we currently use FCA as standard chambers.
Contact allergies to nickel and palladium are known to cross-
react.14-16 In an earlier study,17 we discussed the relevance of contact
allergy to palladium when the patient was not allergic to nickel. After
discussion on preliminary results on triggered Al release from FC, later
published in,12 we raised the question whether positive reactions to
Na-Pd and Pd-Cl without concomitant reactions to nickel sulphate
hexahydrate (Ni) could be an expression of contact allergy to Al.
The aim of this retrospective study was to investigate whether Al
release from FCs could have had any influence on our diagnostic out-
comes of patch testing during the years when we used FCs. Our
research questions were as follows:
1. Is there an overrepresentation of simultaneous contact allergies to
MP, CM II, Na-Pd, and Pd-Cl among patients with Al allergy and, at
the same time, no overrepresentation of simultaneous allergies to
test preparations with substances known to not trigger Al release
in artificial sweat, such as fragrance mix 1 (FM 1), Ni, potassium
dichromate (K-Cr), and tixocortol-21-pivalate (TP)?
2. Is the number of simultaneous positive reactions to possible com-
binations of MP, CM II, Na-Pd, and Pd-Cl higher among patients
with contact allergy to Al compared with patients not allergic
to Al?
3. Is there an overrepresentation of patients with palladium allergy
without simultaneous nickel allergy as compared to those with
both palladium and nickel allergy among patients with contact
allergy to Al?
4. Do patients with a strong Al allergy have more concomitant reac-
tions to MP, CM II, Na-Pd, and Pd-Cl compared to patients with a
weak Al allergy?
5. In cases of an overrepresentation of contact allergies to MP, CM II,
and palladium among patients with contact allergy to Al, is there
also an overrepresentation of these contact allergies when the
patients were tested with FCA?
2 | METHOD AND MATERIAL
2.1 | Method
We conducted a retrospective study of patch test results from 2010–
2019 at the Department of Occupational and Environmental Derma-
tology Skåne University Hospital, Malmö, Sweden. All patch test data
and basic characteristics of the patients were filed in our computer
system, Ekta. For the data analysis, irritant and doubtful reactions
were classified as negative reactions. Positive reactions included +,
++, and +++ reactions.7
2.2 | Subjects
All patients patch tested with FC, the Swedish baseline series, and the
extended Malmö baseline series because of suspected contact allergy
at the Department of Occupational and Environmental Dermatology,
Skåne University Hospital, Malmö, from 01-01-2010 until 31-12-
2017 were included. Corresponding patients tested with FCA from
01-01-2018 until 31-12-2019 were also included. One hundred and
sixty-nine patients were tested two or more times, but these were
counted as one test occasion in this study. In the cases where a
patient had developed new contact allergies at a later test occasion,
all the positive reactions from the past and the present were counted
as one test occasion. Patients who had not been tested with all the
substances (MP, CM II, Na-Pd, Pd-Cl, FM 1, Ni, K-Cr, TP) and patients
who had not been tested with any of the Al substances (aluminium
chloride hexahydrate (Al-Cl) or aluminium lactate (Al-lac)) were
excluded from the study.
2.3 | Patch testing and patch test readings
Table 1 shows the concentration and suppliers of the selected test
substances that were used in our baseline series and our extended
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baseline series during the study period. The patch test preparations
were applied on the upper back of the patients with 20 mg of the test
preparation in 8 mm FC or FCA.7 All test personnel were trained and
their dosing technique was regularly validated during the study period.
The patch tests were removed on day (D) 2. Readings were performed
twice, on D3 or D4 and D7.
2.4 | Ethics
The study was approved by the Regional Ethical Review Board, Lund
Sweden (Dnr 2020/02190). When patients are patch tested they are
informed that data may be used for comparisons on a group level and
approval is mandatory if the patients´ data are stored in the computer
system.
2.5 | Definition
Contact allergy to Al was defined as either a positive reaction to Al-Cl
and/or Al-lac.
Isolated palladium allergy was defined as positive reactions to Na-
Pd and/or Pd-Cl without concomitant reactions to Ni, independent of
any other contact allergy.
2.6 | Statistical analysis
A two-sided Fisher's exact test was performed using SPSS soft-
ware, version 26 (IBM, Armonk, NY) and was used to calculate
whether the difference in prevalence of MP, CMII, Na-Pd, Pd-Cl,
isolated palladium allergy, FM1, Ni, K-Cr, and TP between patients
with and without contact allergy to Al was statistically significant.
The test was also used to calculate whether there was a
statistically significant difference in concomitant reactions in
patients with a strong Al allergy (3+/2+) compared to patients
with a weak Al allergy (1+).
3 | RESULTS
A total of 5446 consecutive patients were patch tested with FC and
the substances Al, MP, CM II, Na-Pd, Pd-Cl, FM 1, Ni, K-Cr, and TP
during 2010–2017; 3636 were female (66.8%) and 1810 were male
(33.2%); mean age was 44.4 years. Forty-eight (0.9%) patients had
contact allergy to Al. Positive patch test reactions to MP, CM II, Na-
Pd, and Pd-Cl were all overrepresented in patients with contact
allergy to Al, whereas positive patch test reactions to FM 1, Ni, K-Cr,
or TP were not. Table 2 shows the prevalence and distribution of con-
tact allergy to the test substances among patients with and without Al
allergy.
Table 3 shows the prevalence of concomitant reactions to MP,
CM II, Na-Pd, and Pd-Cl and concomitant reactions to FM 1, Ni, K-Cr,
and TP in those with and without Al allergy.
Five hundred and twenty-five (9.6%) patients were positive to
either Na-Pd or Pd-Cl. Ten of the palladium-allergic patients had con-
tact allergy to Al (patients 4–10 and 24–26, Table 4); 77 (14.7%)
patients had an isolated palladium allergy. Contact allergy to Al was
significantly overrepresented in those with an isolated palladium
allergy compared to patients with concomitant reactions to nickel and
palladium (5/10 vs 5/448 P < .001).
Among the 48 patients with positive reactions to Al, 20 patients
had 3+ / 2+ reactions to Al and 28 patients had a 1+ reaction
(Table 4). Among the 20 patients with a strong allergy (3+/2+), we
found 19 reactions to MP and/or CM II, and/or Na-Pd, and/or Pd-Cl
out of 80 possible reactions. Among the 28 Al-allergic patients with 1
+ reactions to Al, we found 11 out of 112 possible reactions to MP
and/or CM II, and/or Na-Pd, and/or Pd-Cl (19/80 vs 11/112; two-
TABLE 1 Suppliers and concentration of patch test material for the selected test substances used at the Department of Occupational and
Environmental Dermatology, Skåne University Hospital, Malmö, Sweden, 2010–2019
Substance Supplier Vehicle Concentration w/w, %
Aluminium chloride hexahydrate MPBio-medicials, Inc. Eschwege, Germany Pet. 10
Aluminium lactate Sigma Aldrich, Steinheim, Germany Pet. 12
Myroxolon pereirae Chemotechnique Diagnostics, Vellinge, Sweden Pet. 25
Caine mix II Chemotechnique Pet. 10
Sodium tetrachloro-palladate Sigma Aldrich Pet. 3
Palladium chloride Chemotechnique Pet. 2
Fragrance mix 1 Chemotechnique Pet. 8
Potassium dichromate Chemotechnique Pet. 0.5
Nickel sulphate hexahydrate Chemotechnique Pet. 5
Tixocortol-21-pivalate Chemotechnique Pet. 0.1
Finn Chambers and Finn
Chambers AQUA
(Epitest Ltd Oy, Tuusula, Finland or Smart-Practice, Phoenix, Arizona, USA) mounted on Scanpor tape,
(Norgeplaster A/S) Oslo, Norway
Note: The applied amount is 20 mg in all these cases and the inner chamber area is 0.5 cm2.
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sided Fisher's exact test, P = .015). These results are illustrated in
Figure 1. Figure 2 illustrates that the increased number of concomi-
tant reactions in the group with strong Al allergy was due to an
increased number of patients reacting to one or more of the
corrosion-triggering substances.
A total of 1450 patients were patch tested with FCA during 2018–
2019. Eleven patients were found to have contact allergy to Al (0.8%).
Two of these patients had concomitant reactions to MP (18.2%, 2/11 vs
90/1439); (two-sided Fisher's exact test, P = .15). None of the 11
patients had an isolated palladium allergy or concomitant reactions to
TABLE 2 Number of concomitant positive patch test reactions to the selected test substances stratified by contact allergy to aluminium
Positive reactions to Chamber Number (%) Aluminium positive (%) Aluminium negative (%) P-value
Myroxolon pereirae Finn Chambers 340/5446 (6.2) 8/48 (16.7) 332/5398 (6.2) .009
Finn Chambers AQUA 92/1450 (6.3) 2/11 (18.2) 90/1439 (6.2) .15
Caine mix II Finn Chambers 78/5446 (1.4) 4/48 (8.3) 74/5398 (1.4) .005
Finn Chambers AQUA 16/1450 (1.1) 0 16/1439 (1.1)
Sodium tetrachloro-palladat e Finn Chambers 489/5446 (9.0) 9/48 (18.8) 480/5398 (8.9) .036
Finn Chambers AQUA 172/1450 (11.9) 1/11 (9.1) 171/1439 (11.8) >.99
Palladium chloride Finn Chambers 382/5446(7.0) 9/48 (18.8) 373/5398 (6.9) .005
Finn Chambers AQUA 124/1450 (8.6) 1/11 (9.1) 123/1439 (8.5) >.99
Isolated palladiuma Finn Chambers 77/5446 (1.4) 5/48 (10.4) 72/5398 (1.3) .001
Finn Chambers AQUA 38/1450 (2.6) 0 38/1439 (2.6)
Nickel sulphate hexahydrate Finn Chambers 924/5446 (17.0) 6/48 (12.5) 918/5398 (17.0) .56
Fragrance mix 1 Finn Chambers 320/5446 (5.9) 4/48 (8.3) 316/5398 (5.9) .37
Tixocortol-21-pivalate Finn Chambers 53/5446 (1.0) 1/48 (2.1) 52/5398 (1.0) .38
Potassiom dichromate Finn Chambers 303/5446 (5.6) 4/48 (8.3) 199/5398 (3.7) .1
Note: Statistically significant differences among the patients with and without aluminium allergy (P < .05) are marked in bold.
aIsolated palladium indicates contact allergy to sodium tetrachloropalladate and or palladium chloride without a simultaneous nickel allergy.
TABLE 3 Number of positive reactions to different combinations of concomitant reactions to the aluminium corrosion triggering test
substances and to test substances not triggering aluminium release in artificial sweat
Positive reactions for: Number (%) Aluminium positive (%) Aluminium negative(%) P-value
MP + CMII 19/5446 (0.3) 3/48 (6.3) 16/5398 (0.3) <.001
MP + Na-Pd 42/5446 (0.8) 2/48 (4.2) 40/5398 (0.7) .052
CMII + Na-Pd 15/5446 (0.3) 2/48 (4.2) 13/5398 (0.24) .007
MP + CMII + Na-Pd + Pd-cl 4/5446 (0.07) 48(2.1) 3/5398 (0.06) .04
MP + Pd-cl 32/5446 (0.6) 2/48 (4.2) 30/5398 (0.6) .03
CMII + Pd-cl 11/5446 (0.2) 2/48(4.2) 9/5398 (0.17) .004
FM1 + K-Cr 27/5446 (0.5) 2/48(4.2) 25/5398 (0.5) .02
FM1 + Ni 66/5446 (1.2) 1/48(0.2) 65/5398 (1.2) .44
FM1 + TP 12/5446 (0.2) 0 12/5398 (0.2) >.99
FM1 + K-Cr + Ni 9/5446 (0.2) 1/0.2 8/5398 (0.15) .08
K-Cr + Ni 58/5446 (1.1) 1/0.2 57/5398 (1.1) .40
FM1 + K-Cr + Ni + TP 1/5446 (0.02) 0 1/5398 (0.02) >.99
FM1 + K-Cr + TP 1/5446 (0.02) 0 1/5398 (0.02) >.99
FM1 + Ni + TP 2/5446 (0.04) 0 2/5398 (0.04) >.99
K-Cr + Ni + TP 1/5446 (0.02) 0 1/5398 (0.02) >.99
K-Cr + TP 2/5446 (0.04) 0 2/5398 (0.04) >.99
Ni + TP 10/5446 (0.2) 0 10/5398 (0.2) >.99
Note: The patch test results are stratified by contact allergy to aluminium. Statistically significant differences among the patients with and without
aluminium allergy (P < .05) are marked in bold.
Abbreviations: CMII, caine mix II; FM1, Fragrance mix 1; K-Cr, potassium dichromate; MPk, Myroxylon pereirae; Na-pd, sodium tetrachloropalladate; Ni,
nickel sulphate hexahydrate; Pd-Cl, palladium chloride; TP, tixocortol-21-pivalate.
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CM II. One of the 11 patients (9.1%) with positive reactions to Na-Pd
and Pd-Cl had a positive reaction to Ni. The prevalence of Na-Pd and
Pd-Cl reactions among patients negative to Al was 11.9% and 8.6%,
respectively. A comparison of the prevalence of Na-Pd and Pd-Cl reac-
tions among patients with and without aluminium allergy was not signifi-
cant (two-sided Fisher's exact test).
TABLE 4 Forty-eight patients were positive to aluminium chloride hexahydrate and/or aluminium lactate during 2010–2017
Aluminium patch test reaction Patients number Myroxylon pereirae Caine mix II Na₂PdCl₄ PdCl₂
3+ 1–3  -  
4  - Positive Positive
5 Positive Positive Positive Positive
6 Positive  Positive Positive
2+ 7–9   Positive Positive
10   Positive 
11–13 Positive   
14–20    
21 Positive   
22–23 Positive Positive  
1+ 24  Positive Positive Positive
25   Positive Positive
26    Positive
27–48    
Note: The patients grade of allergy to aluminium is shown together with their concomitant reactions to Myroxylon pereirae, caine mix II, sodium
tetrachloropalladate (Na₂PdCl₄), and palladium chloride (PdCl₂).
Abbreviation: , negative.
F IGURE 1 Percentage of aluminium (Al)-allergic patients. (28 with 1+ and 20 patients with 2+/3+ reactions) with concomitant reactions to
Myroxylon pereirae, caine mix II, sodium tetrachloropalladate, and palladium chloride. The number of concomitant reactions was significantly
higher among the patients with 2+/3+ Al allergy compared to patients with 1+ Al allergy, (two-sided Fisher's exact test: P = .015). Each column
represents the percentage of reactions to the specific test substance out of the number of possible reactions. For example, among the patients
with a 2+/3+ allergy to Al, there were five reactions to Myroxylon pereirae out of 20 possible reactions (25%). The turquoise column represents
the total number of reactions out of the total numbers of possible reactions to Myroxylon pereirae, caine mix II, sodium tetrachloropalladate, and
palladium chloride in each group
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4 | DISCUSSION
Because contact allergy to Al is rare, Al-Cl or Al-lac are not included in
the European baseline series. The earlier recommended patch test
concentration of Al-Cl (2.0%) is lower than the elicitation threshold
for many Al-allergic patients.10 Today, the recommended test prepara-
tion for tracing Al allergy is Al-Cl, 10% pet.10,18,19 In Malmö, we have
tested this preparation and a preparation with Al-lac 12% pet. since
February 2010. This provides us with unique data on Al-allergic
patients and an opportunity to investigate whether the laboratorie
results (in artificial sweat) from Hedberg et al. could have any impact
on our clinical work. Hedberg et al. found the highest Al release from
FC filled with Na-Pd 3% pet.12 According to Hedberg et al., this Al
release would correspond to an Al patch test dose of 0.5% Al-Cl,
which is a low concentration compared to the doses used for patch
testing in Malmö. However, some patients will test positively to a
dose corresponding to 0.5% Al-Cl or lower.10,20 It was, hence, not sur-
prising that we found an overrepresentation of Al allergy among
patients with positive reactions to Na-Pd, MP, CM II, and Pd-Cl, which
all caused high Al release in the previous studies compared to an
empty FC (Table 2). These overrepresentations of simultaneous con-
tact allergies to Na-Pd, MP, CM II, and Pd-Cl in Al-allergic patients
indicated that one explanation for some of these simultaneous con-
tact allergies was false-positive reactions.
Positive reactions to palladium often follow nickel allergy and
have most often been explained as cross-sensitization, because nickel
and palladium have similar chemical structures.14,17 The palladium
reaction is, therefore, often neglected if the patient is also allergic to
nickel. However, if a patient has an isolated palladium reaction, it is
often difficult to explain the exposure and clinical relevance, at least
in Sweden, where palladium is not used in dental alloys.21 In one of
our earlier studies,17 which was performed while we still used FC, we
suggested that isolated palladium allergy could be due to contact
allergy to Al. The group of palladium-allergic patients, thus, consists of
those with and without simultaneous contact allergy to nickel. We
found that Al allergy was overrepresented among patients with an iso-
lated palladium allergy (P < .001, Table 2). The results, thus, support
our previous hypothesis that a positive reaction to palladium alone,
apart from being a true palladium allergy, may actually be a false-
positive reaction due to a strong contact allergy to Al when patch
testing with FC.
It was apparent that patients with Al allergy tested with FC more
often had concomitant reactions to more than one of the four sub-
stances (MP, CM II, Na-Pd, and Pd-Cl), compared to Al-negative
patients (Table 3). Also, patients with a strong Al allergy hade more
concomitant reactions to MP, CM II, Na-Pd and Pd-Cl than patients
with a weak Al allergy (Figures 1 and 2).
To ensure that our results were not caused by coincidental aller-
gies, we chose to calculate the prevalence of Al allergy among patients
with contact allergies to a group of other test substances that were
shown to have a lower or similar Al release than an empty FC,
according to Hedberg et al.12 FM 1 was chosen because it contains
common perfume allergens, just as MP. K-Cr and Ni were selected
because they are common metal allergens with a high sensitization
prevalence among dermatitis patients, similarly to the two palladium
salts. TP was chosen because it is closely related to hydrocortisone, a
substance found in topical medications such as CM II. No overrepre-
sentation of Al allergy was found among patients with contact allergy
to these four substances causing low or no Al-release (Table 2), which
supports our hypothesis. When different combinations of contact
allergy to FM 1, K-Cr, Ni, and TP were investigated we found an over-
representation of Al allergy in those with contact allergy to FM 1 and
K-Cr, but not for any other combinations of contact allergy to the four
chosen substances and Al (Table 3).
FC were introduced in 1975 by V Pirilä V, Finland.1 There are only
a few case reports about patients with Al allergy reacting to FC when
patch tested.22-25 Testing with only an empty FC is insufficient to
detect Al allergy and not recommended for that purpose.10,18,19 This
is not the first time that patch test substances and their interactions
with Al in FC have been investigated. In 1985, Fischer and Maibach
investigated the reaction of cobalt and nickel salts with Al in FC
in vitro. Even though they found that nickel and cobalt did react with
Al on the surface in the chambers, they concluded that pet, which is
used routinely as vehicle in patch testing, seems to protect the surface
in the chambers from corrosion from these two metal salts.26 This is
very much in line with the results from Hedberg et al.12 investigating
Al release from an empty FC exposed to artificial sweat and FC with
32 different baseline preparations. They found that many patch test
preparations resulted in a significantly lower release of Al compared
with an empty FC,12 probably due to the protection of pet.; however,
test substances with high amounts of chloride (Na-Pd, Pd-Cl) and acid
F IGURE 2 The number of patients with concomitant reactions to
any of the four substances causing aluminium (Al) release. Twenty-
eight patients had a 1+ reaction and 20 patients had 2+/3+ reactions
to Al. The figure shows the number of patients with concomitant
reactions to one or more of the four test substances in each group.
The number of patients with concomitant reactions was higher among
patients with 2+/3+ reactions to Al (two-sided Fisher's exact
test: P < .001)
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(MP, CM II) caused corrosion to the Al surface. This corrosion and sec-
ondary Al release was not found for FCA.12 To further support our
findings and the results from the laboratory study by Hedberg et al.,
we investigated the patch test data from 2018–2019, where we have
been using FCA. We found approximately the same prevalence of Al
allergy, (0.9% during 2010–2017 vs 0.8% during 2018–2019) and the
same prevalence of MP allergy (6.2% during 2010–2017 vs 6.3% dur-
ing 2018–2019). We did not find any statistical overrepresentation of
MP allergy among patients with Al allergy when testing with FCA.
Clinically, false-positive reactions to MP, CM II, Na-Pd, and Pd-Cl
in Al-allergic patients may have a substantial impact on the diagnos-
tics, management, and prevention of contact dermatitis. One way to
avoid false-positive reactions due to Al release from FC is the use of
another test chamber, such as FCA, and various plastic chambers such
as Van der Bend and IQ chambers. It is not a trivial matter to change
the patch test system in a patch test clinic. New guidelines and other
routines regarding dosing and taping of the new system will be
needed.27 Physicians and clinicians would have to learn the new test
systems, their advantages and disadvantages, and possible new false-
positive reactions.28,29 If FC are used, it is recommended to also test
all patients with Al-Cl in the baseline series. Whenever positive reac-
tions are noted to Al-Cl and MP or CM II or Na-Pd or Pd-Cl, additional
patch testing with the latter allergens should be performed in a test
system that does not release Al.
5 | CONCLUSION
Testing with Al FC may give false-positive reactions to MP, CM II, Na-
Pd, and Pd-Cl due to contact allergy to Al and triggered Al corrosion
by these substances. Patients with a strong Al allergy could have more
false-positive reactions as compared to patients with a weak Al
allergy. The use of patch test chambers not releasing Al, for example
FCA, or a plastic chamber, such as Van der Bend and IQ chambers, will
eliminate the risk of false-positive reactions to MP, CMII, Na-Pd, and
Pd-Cl in Al-allergic patients.
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